Neurocrine Biosciences Statistics
Total Valuation
NBIX has a market cap or net worth of $15.73 billion. The enterprise value is $15.44 billion.
| Market Cap | 15.73B |
| Enterprise Value | 15.44B |
Important Dates
The last earnings date was Monday, November 2, 2026, after market close.
| Earnings Date | Nov 2, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NBIX has 101.22 million shares outstanding. The number of shares has increased by 1.98% in one year.
| Current Share Class | 101.22M |
| Shares Outstanding | 101.22M |
| Shares Change (YoY) | +1.98% |
| Shares Change (QoQ) | +0.96% |
| Owned by Insiders (%) | 1.20% |
| Owned by Institutions (%) | 102.25% |
| Float | 99.91M |
Valuation Ratios
The trailing PE ratio is 23.07 and the forward PE ratio is 13.05. NBIX's PEG ratio is 0.33.
| PE Ratio | 23.07 |
| Forward PE | 13.05 |
| PS Ratio | 4.28 |
| Forward PS | 3.53 |
| PB Ratio | 4.09 |
| P/TBV Ratio | 13.35 |
| P/FCF Ratio | 15.24 |
| P/OCF Ratio | 14.87 |
| PEG Ratio | 0.33 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.56, with an EV/FCF ratio of 14.97.
| EV / Earnings | 22.15 |
| EV / Sales | 4.20 |
| EV / EBITDA | 14.56 |
| EV / EBIT | 15.79 |
| EV / FCF | 14.97 |
Financial Position
The company has a current ratio of 2.04, with a Debt / Equity ratio of 0.12.
| Current Ratio | 2.04 |
| Quick Ratio | 1.72 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | 0.40 |
| Debt / FCF | 0.43 |
| Interest Coverage | 307.97 |
Financial Efficiency
Return on equity (ROE) is 20.41% and return on invested capital (ROIC) is 20.19%.
| Return on Equity (ROE) | 20.41% |
| Return on Assets (ROA) | 12.45% |
| Return on Invested Capital (ROIC) | 20.19% |
| Return on Capital Employed (ROCE) | 21.23% |
| Weighted Average Cost of Capital (WACC) | 5.91% |
| Revenue Per Employee | $1.48M |
| Profits Per Employee | $281,000 |
| Employee Count | 2,500 |
| Asset Turnover | 0.75 |
| Inventory Turnover | 19.32 |
Taxes
In the past 12 months, NBIX has paid $229.60 million in taxes.
| Income Tax | 229.60M |
| Effective Tax Rate | 24.63% |
Stock Price Statistics
The stock price has increased by +13.86% in the last 52 weeks. The beta is 0.33, so NBIX's price volatility has been lower than the market average.
| Beta (5Y) | 0.33 |
| 52-Week Price Change | +13.86% |
| 50-Day Moving Average | 149.16 |
| 200-Day Moving Average | 149.47 |
| Relative Strength Index (RSI) | 49.96 |
| Average Volume (20 Days) | 1,456,679 |
Short Selling Information
The latest short interest is 5.90 million, so 5.83% of the outstanding shares have been sold short.
| Short Interest | 5.90M |
| Short Previous Month | 6.45M |
| Short % of Shares Out | 5.83% |
| Short % of Float | 5.91% |
| Short Ratio (days to cover) | 4.53 |
Income Statement
In the last 12 months, NBIX had revenue of $3.70 billion and earned $702.50 million in profits. Earnings per share was $6.73.
| Revenue | 3.70B |
| Gross Profit | 2.39B |
| Operating Income | 985.50M |
| Pretax Income | 932.10M |
| Net Income | 702.50M |
| EBITDA | 1.07B |
| EBIT | 985.50M |
| Earnings Per Share (EPS) | $6.73 |
Balance Sheet
The company has $737.90 million in cash and $451.80 million in debt, with a net cash position of $286.10 million or $2.83 per share.
| Cash & Cash Equivalents | 737.90M |
| Total Debt | 451.80M |
| Net Cash | 286.10M |
| Net Cash Per Share | $2.83 |
| Equity (Book Value) | 3.88B |
| Book Value Per Share | 38.29 |
| Working Capital | 1.02B |
Cash Flow
In the last 12 months, operating cash flow was $1.07 billion and capital expenditures -$26.10 million, giving a free cash flow of $1.04 billion.
| Operating Cash Flow | 1.07B |
| Capital Expenditures | -26.10M |
| Depreciation & Amortization | 83.60M |
| Net Borrowing | n/a |
| Free Cash Flow | 1.04B |
| FCF Per Share | $10.27 |
Margins
Gross margin is 64.67%, with operating and profit margins of 26.62% and 18.98%.
| Gross Margin | 64.67% |
| Operating Margin | 26.62% |
| Pretax Margin | 25.18% |
| Profit Margin | 18.98% |
| EBITDA Margin | 28.88% |
| EBIT Margin | 26.62% |
| FCF Margin | 28.09% |
Dividends & Yields
NBIX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -1.98% |
| Shareholder Yield | -1.98% |
| Earnings Yield | 4.33% |
| FCF Yield | 6.56% |
Analyst Forecast
The average price target for NBIX is $208.54, which is 34.20% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $208.54 |
| Price Target Difference | 34.20% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 28 |
| Revenue Growth Forecast (3Y) | 21.10% |
| EPS Growth Forecast (3Y) | 33.93% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
NBIX has an Altman Z-Score of 6.72 and a Piotroski F-Score of 6.
| Altman Z-Score | 6.72 |
| Piotroski F-Score | 6 |